コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 ADH (alcohol dehydrogenase) gene expression, enzyme acti
2 ADH and its cofactor nicotinamide adenine dinucleotide (
3 ADH is caused by mutations in the low-density lipoprotei
4 ADH peptides induced the production of interferon-gamma
5 ADH performed an onsite investigation at clinic A on 7 S
6 ADH performed an onsite investigation at Clinic A on Sep
7 ADH-1 enhancement of response to melphalan was associate
8 ADH-1 improved responses to regional LPAM but had variab
9 ADH-1 in combination with LPAM ILI improved antitumor re
10 ADH-1 increased vascular permeability without effecting
11 ADH-1 is a cyclic pentapeptide that disrupts N-cadherin
12 ADH-41 targets Abeta in a sequence and structure-specifi
13 ADH-41 was also effective at inhibiting the seed-catalyz
14 ADH-specific peripheral T-cell responses were assessed b
15 ADH-specific T-cell responses have not been characterize
17 tabolizing enzymes alcohol dehydrogenase 1B (ADH-1B; rs1229984) and alcohol dehydrogenase 1c (ADH-1C;
19 odococcus ruber (ADH-A), whereas evo-1.1.200 ADH led to their counterpart (R)-enantiomers also with c
20 s, 93 were analyzed, providing data for 6458 ADHs (5911 were managed with surgical excision and 547 w
23 no-3,7-dideoxy-d-threo-hept-6-ulosonic acid (ADH) synthase, the product of the Mj0400 gene, catalyzes
24 nerates the endocrine lobe [adenohypophysis (ADH)] of the pituitary, a master gland controlling growt
25 arison of the enzyme with related aldolases, ADH synthase is classified as a new member of the class
26 ehydrogenase (either metagenomic ADH-150, an ADH from Sphingobium yanoikuyae (SyADH), or a variant of
29 vating mutation in this region, V836L, in an ADH patient, we studied the remaining residues in this r
33 This imbalance between gene expression and ADH activity at 10 degrees C, as well as the unexpected
34 ng that ChREBP regulates EtOH metabolism and ADH activity through its direct control of sirtuin 1 exp
36 irected to alcohol dehydrogenase (ADH), anti-ADH titers being associated with disease severity and ac
39 ial hypercholesterolemia 4 (FH4), defined as ADH in absence of mutations in these genes and thereafte
40 ment of highly homologous isoenzymes such as ADHs where multiple signature peptides can be examined b
41 ressed genes between DCIS-HN and 447 between ADH-HN, with >90% of the ADH-HN genes also present among
42 ced a co-ordinated regulatory action between ADH genes, especially between ADH1A and ADH1C within the
44 1 (E-47 cells) were exposed to ethanol, both ADH- and CYP2E1-generated products reduced STAT1 phospho
45 and bienzymatic (anchoring sequentially both ADH and aldehyde dehydrogenase) systems were tested.
54 used the mouse hepatocyte cell line (CYP2E1/ADH-transfected HepB5 cells) or primary mouse hepatocyte
55 ydrogenase (ALDH) and alcohol dehydrogenase (ADH) active sites reside at the outer surface and the in
56 because inhibition of alcohol dehydrogenase (ADH) activity blunted ChREBP EtOH-induced acetylation in
57 sic functional trait, alcohol dehydrogenase (ADH) activity in D. melanogaster, across both historical
58 ionships between some alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) genes and alcohol
59 e catabolism in which alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) play central role
61 the activation of the alcohol dehydrogenase (ADH) and greater anaerobic metabolism in comparison with
62 betaL crystallin and alcohol dehydrogenase (ADH) and significantly less effective than wt alphaB cry
63 e dismutase (SOD) and alcohol dehydrogenase (ADH) as protein models] showed the integrity of the Zn-b
65 hol oxidase (AOx) and alcohol dehydrogenase (ADH) biocatalysis towards butanol-1 oxidation by incorpo
66 tigated bioanode with alcohol dehydrogenase (ADH) catalysing oxidation of glycerol and glyceraldehyde
68 ns in hepatic Class 1 alcohol dehydrogenase (ADH) expression in ethanol-fed rats correspondent with r
72 aimed to test whether alcohol dehydrogenase (ADH) gene variants were associated with alcohol use befo
75 l (PBMC) responses to alcohol dehydrogenase (ADH) in patients with alcohol-related cirrhosis, associa
77 ine-51 in horse liver alcohol dehydrogenase (ADH) is part of a hydrogen-bonded system that appears to
79 Polymorphism in the alcohol dehydrogenase (ADH) protein of Drosophila melanogaster, like genetic va
80 yde produced from the alcohol dehydrogenase (ADH) reaction was shown to improve the linearity of NAD(
81 ll extant short-chain alcohol dehydrogenase (ADH) through retroposition, provides an opportunity to e
82 the immobilization of alcohol dehydrogenase (ADH) via Nafion entrapment, with excellent analytical ch
83 mammals catalyzed by alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), flavin-containing m
84 zyme, hepatic Class I alcohol dehydrogenase (ADH), and this mechanism involves regulated CCAAT/enhanc
85 ntibodies directed to alcohol dehydrogenase (ADH), anti-ADH titers being associated with disease seve
86 nzyme family) with an alcohol dehydrogenase (ADH), applying the in situ substrate feeding product rem
87 a potent inhibitor of alcohol dehydrogenase (ADH), decreased the conversion of [3H]20-HETE to 20-COOH
90 relation of maternal alcohol dehydrogenase (ADH)1B genotype (rs1229984) with these outcomes (the A a
91 zing a single enzyme, alcohol dehydrogenase (ADH)] and bienzymatic (anchoring sequentially both ADH a
92 structural changes of alcohol dehydrogenase (ADH, 4mer) under varying degrees of in-source activation
93 ependent alcohol and aldehyde dehydrogenase (ADH and AldDH) enzymes for biofuel cell applications.
95 latinum) and enzymes (alcohol dehydrogenase, ADH; lactate dehydrogenase, LDH; xanthine oxidase, XOx;
97 nto retinaldehyde by alcohol dehydrogenases (ADHs) or retinol dehydrogenases (RDHs); and oxidation of
100 s obtained here, DET using the PQQ-dependent ADH and AldDH still lacks high current density, while th
101 entiate between the methods used to diagnose ADH, which may be related to the size of the ADH focus.
103 roups of the CWP to adipic acid dihydrazide (ADH)-derivatized protein, and (ii) binding of the carbod
106 (21%), the diagnosis was upgraded to either ADH or DCIS (exact two-sided 95% CI = 11.4%, 36.4%).
107 new architecture can up-regulate endogenous ADH activity by > 20-fold in transgenic Arabidopsis.
110 CI: 1.2, 10) more likely in mass (n = 20 for ADH and n = 20 for DCIS) than in non-mass (n = 46 for AD
111 = 20 for DCIS) than in non-mass (n = 46 for ADH and n = 97 for DCIS), compared with nonunderestimati
112 ears, met modified Simon-Broome criteria for ADH and were screened for mutations in the exons and con
118 uly 2018, the Arkansas Department of Health (ADH) was notified by hospital A of 3 patients with blood
119 uly 2018, the Arkansas Department of Health (ADH) was notified by Hospital A of three patients with b
120 oncentration, the antiparallel double helix (ADH) conformation was observed to be most abundant for G
121 patient-matched histologically normal (HN), ADH, and DCIS from 12 patients with estrogen receptor po
122 of a thermophilic alcohol dehydrogenase (ht-ADH): Y25A (at the dimer interface) and V260A (at the co
123 tant thermophilic alcohol dehydrogenases (ht-ADH), presenting evidence for Arrhenius prefactor values
124 Arrhenius curves previously reported for ht-ADH are proposed to arise, at least in part, from a chan
125 dynamical transition at 30 degrees C for ht-ADH, the temperature dependence of the KIE is seen to in
127 esidues in the cofactor-binding pocket of ht-ADH (Leu176 and V260) have been mutated to a series of h
128 a thermolabile psychrophilic homologue of ht-ADH, ps-A25Y, leads to a more thermostable enzyme and a
129 ogenase from Bacillus stearothermophilus (ht-ADH) has been mutated at an aromatic side chain in the a
131 ced temperature alters the ability of the ht-ADH variants to sample the catalytically relevant region
134 Autosomal-dominant hypercholesterolemia (ADH) is characterized by elevated low-density lipoprotei
135 ND- Autosomal dominant hypercholesterolemia (ADH), characterized by elevated plasma levels of low-den
136 a diagnosis of atypical ductal hyperplasia (ADH) (75 of 6,081 [1.2%]) were reviewed; these patients
137 erestimation of atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS) at magnetic res
138 djacent foci of atypical ductal hyperplasia (ADH) in eight, and well-differentiated papillary ductal
141 plasia (SH) and atypical ductal hyperplasia (ADH), are candidate precursors to ductal carcinoma in si
143 tients with autosomal dominant hypocalcemia (ADH) repressed the transcription of miR-9 and miR-374 ge
144 bjects with autosomal dominant hypocalcemia (ADH), five appear at the junction of TM helices 6 and 7
149 eated hepatocytes, a significant decrease in ADH protein content and/or acetylation was observed.
155 Conclusion The rates of underestimation in ADH and DCIS diagnosed at MR imaging-guided vacuum-assis
156 The EcD-based biosensor that incorporates ADH, NAD(+), Pd-NPs and Nafion showed no loss of enzyme
157 the molecular mechanism for ethanol-induced ADH expression during the UEC pulse in adult male rats f
159 her these results indicate that class I-like ADH is conserved in zebrafish, albeit with mixed functio
160 le alcohol dehydrogenase (either metagenomic ADH-150, an ADH from Sphingobium yanoikuyae (SyADH), or
164 paucity of data about the molecular basis of ADH among ethnic groups other than those of European or
165 Here, we examined the molecular basis of ADH in a multiethnic patient cohort from lipid clinics i
168 hen catalyzes deamination and cyclization of ADH, resulting in DHQ, which is fed into the canonical p
169 at NPS 2143 corrects the molecular defect of ADH mutations for treatment of this disease are also dis
170 included 955331 women with 1727 diagnoses of ADH, 1058 (61.3%) of which were diagnosed by core biopsy
178 ansgenes to map the functional divergence of ADH enzyme activity in vivo, we find that amino acid sub
179 Cell-based assays to assess the effect of ADH-41 on Abeta are underway and will be presented in du
181 tly higher in cases of three or more foci of ADH (15 [28%] of 53 cases) than in cases of fewer than t
186 to ethanol vapor, the enzymatic reaction of ADH and ethanol transforms NAD(+) into NADH, which cause
189 the charge at the "unfolding" N-terminus of ADH decreased at high in-source activation energies afte
191 pattern of regulation is similar to that of ADH that encodes alcohol dehydrogenase, which we have re
193 tudied the effects of insulin and ethanol on ADH gene expression in a highly differentiated rat hepat
195 en it was placed under anoxia; the two other ADH homologs encoded on the Chlamydomonas genome do not
196 We hypothesized that the novel pentapeptide (ADH-1), which disrupts N-cadherin adhesion, could sensit
198 tion of OYE2 with a Prelog or an anti-Prelog ADH allowed the preparation of the secondary alcohols wi
200 tivation was not observed for charge-reduced ADH, which likely adopted compact structures that are re
202 lcohol dehydrogenase from Rhodococcus ruber (ADH-A), whereas evo-1.1.200 ADH led to their counterpart
203 Further, endoderm can generate a rudimentary ADH-like structure in the near absence of ectodermal con
205 eotide polymorphisms (SNPs) across the seven ADH genes and analyzed their association with alcoholism
208 xpression system for Sulfolobus solfataricus ADH-10 (Alcohol Dehydrogenase isozyme 10) and its use in
211 In a preclinical animal model, systemic ADH-1 given with regional melphalan demonstrated synergi
212 e found that across all environments tested, ADH activity was largely influenced by a single QTL enco
215 n D. melanogaster has also demonstrated that ADH activity is plastic in response to alcohol concentra
216 These data provide genetic evidence that ADH (but not SH) are often precursors to cancer and sugg
217 and atomic force microscopy (AFM) show that ADH-41 wholly suppresses the aggregation of Abeta at a s
219 two peaks in the ADH region suggesting that ADH populations are composed of two distinct conformers.
222 e-nucleotide polymorphisms (SNPs) across the ADH clusters in a global sampling of 42 populations.
228 has the highest F(st) of the 54 SNPs in the ADH cluster, and it is significantly above the mean F(st
229 -95 and other discontinuous sequences in the ADH peptide, whereas only one sequence was targeted in a
230 spectrometry data revealed two peaks in the ADH region suggesting that ADH populations are composed
234 bium yanoikuyae (SyADH), or a variant of the ADH from Thermoanaerobacter ethanolicus (TeSADH W110A))
235 that SREBP-1 is a negative regulator of the ADH gene and may work in concert with the CCAAT/enhancer
237 genes, including the two known genes of the ADH pathway, kauB and gbuA, were found to be inducible b
238 encode enzymes for the initial steps of the ADH pathway, the potential physiological functions of th
239 tOH attenuates the antiviral function of the ADH-ALDH pathway, which suggests the possibility that Et
242 mic amperometric detection of ethanol on the ADH-Nafion/NiOxNPs/GC modified electrode gives linear re
244 nd identified novel risk loci mapping to the ADH gene cluster on chromosome 4 and extending centromer
246 pecificity of nuclear protein binding to the ADH-SRE site was confirmed using antibody and UV cross-l
248 In hypophysectomized rats, in which the ADH protein increased by approximately 6-fold, the nucle
249 s C already at 10%wl in a synchrony with the ADH activity, indicating a rapid response likely due to
251 fluenza vaccination were consistent with the ADH and may have contributed to findings of low VE acros
253 three genes are tandemly arrayed within the ADH cluster on chromosome 4 and have very high nucleotid
255 nt study, we genotyped 16 markers within the ADH gene cluster (including the ADH1A, ADH1B, ADH1C, ADH
257 Further, sequence analysis shows that these ADHs form a monophyletic group along with additional fam
260 The in vivo binding status of SREBP-1 to ADH-SRE sites, as measured by the chromatin immunoprecip
261 ggest that additional loci may contribute to ADH, especially in understudied populations such as blac
263 utbreak include adding extrapulmonary NTM to ADH's reportable disease list and providing more oversig
270 a plastidic arogenate dehydrogenases (TyrAa /ADH) encoded by two ADH genes (BvADHalpha and BvADHbeta)
272 tored in real time, show N(tz)AD(+) and N(tz)ADH to be substrates for yeast alcohol dehydrogenase and
273 e is seen as N(tz)AD(+) is converted to N(tz)ADH, reflecting a complementary photophysical behavior t
276 s with LDLR variants, those with unexplained ADH had lower levels of LDL-cholesterol (292 +/- 47 mg/d
278 Chaperone activity was determined by using ADH, insulin, and betaL-crystallin as the target protein
282 Surgical excision is recommended even when ADH involves fewer than three foci and all mammographic
283 most effective bioanode was fabricated when ADH was immobilized on gold nanoparticles (AuNPs) modifi
286 e based on cohorts that included women whose ADH was diagnosed before widespread use of screening mam
287 d with ADH is slightly lower for women whose ADH was diagnosed by needle core biopsy compared with ex
289 the risk of invasive cancer associated with ADH diagnosed using core needle biopsy vs excisional bio
291 port here that melphalan in combination with ADH-1 significantly reduced tumor growth up to 30-fold o
294 When the bioreductions were performed with ADH-A from Rhodococcus ruber overexpressed in E. coli, n
295 95% CI, 3.0%-12.8%) compared with those with ADH diagnosed via core needle biopsy (5%; 95% CI, 2.2%-8
300 Phylogenetic analysis of these zebrafish ADHs indicates that they share a common ancestor with ma